Figure 2.
A, Time to protocol-defined virologic failure in those with screening plasma HIV RNA<105 copies/mL. B, Proportion of patients in low HIV RNA stratum with HIV RNA level <50 copies/mL and 95% binomial confidence intervals at each study week where analysis includes patients with available data, regardless of whether they had previously switched therapy or met criteria for virologic failure. C, Time to regimen completion (time to the first occurrence of either confirmed virologic failure or discontinuation of initially randomized regimen) in low HIV RNA stratum. D, Time to protocol-defined virologic failure in the high HIV RNA stratum.